Save time and get answers to complex questions with AI chat
Guselkumab brand name?Pramlintide fda approval date?What's the recommended schedule for lurbinectedin side effect checks?How to apply for vascepa's patient assistance?Prolia and osteonecrosis?
See the DrugPatentWatch profile for Retevmo
Retevmo (selinexor) is a prescription cancer drug. As of my last update, there isn’t a publicly listed, widely available authorized supplier for Retevmo in India. Availability in India would typically occur only through approved channels (hospitals’ formulary or licensed import via regulatory clearance). I can help you check current status if you’d like, but here are practical steps to pursue legitimately: - Speak with the treating oncologist about whether selinexor is approved in India or if there’s a local alternative. The doctor can advise on approved options or access pathways. - Check with the Central Drugs Standard Control Organization (CDSCO) or the hospital’s pharmacy about whether selinexor is registered and which companies distribute it in India. - Contact Karyopharm Therapeutics’ patient support or the drug’s official site for information on authorized distributors and any patient-access programs or compassionate-use options. - If there’s no local approval, any import would require formal authorization (often via the hospital or a licensed importer) and a valid prescription from a physician. Do not use unverified sources or online sellers. If you’d like, tell me your city or hospital, and I can help you draft a query for your oncologist or look up the latest regulatory status.
Other Questions About Retevmo :